Abstract

The effects of diabetes and lipoprotein lipase (LpL) on plasma lipids were studied in mice expressing human apolipoprotein B (HuBTg). Our overall objective was to produce a diabetic mouse model in which the sole effects of blood glucose elevation on atherosclerosis could be assessed. Mice were made diabetic by intraperitoneal injection of streptozotocin, which led to a 2- to 2.5-fold increase in plasma glucose. Lipids were assessed in mice on chow and on an atherogenic Western type diet (WTD), consisting of 21% (wt/wt) fat and 0.15% (wt/wt) cholesterol. Plasma triglyceride and cholesterol were the same in diabetic and non-diabetic mice on the chow diet. On the WTD, male diabetic HuBTg mice had a >50% increase in plasma cholesterol and more very low density lipoprotein (VLDL) cholesterol and triglyceride as assessed by FPLC analysis. A Triton study showed no increase in triglyceride or apolipoprotein B production, suggesting that the accumulation of VLDL was due to a decrease in lipoprotein clearance. Surprisingly, the VLDL increase in these mice was not due to a decrease in LpL activity in postheparin plasma. To test whether LpL overexpression would alter these diabetes-induced lipoprotein changes, HuBTg mice were crossed with mice expressing human LpL in muscle. LpL overexpression reduced plasma triglyceride, but not cholesterol, in male mice on WTD. Aortic root atherosclerosis assessed in 32-week-old mice on the WTD was not greater in diabetic mice.▪ In summary, diabetes primarily increased plasma VLDL in HuBTg mice. LpL activity was not decreased in these animals. However, additional LpL expression eliminated the diabetic lipoprotein changes. These mice did not have more atherosclerosis with diabetes.—Kako, Y., L-S. Huang, J. Yang, T. Katopodis, R. Ramakrishnan, and I. J. Goldberg. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis.

Highlights

  • The effects of diabetes and lipoprotein lipase (LpL) on plasma lipids were studied in mice expressing human apolipoprotein B (HuBTg)

  • Mouse plasma has almost an order of magnitude fewer apoB lipoproteins than human plasma, and the major cholesteroltransporting lipoprotein in the mouse is high density lipoprotein (HDL). This difference in lipoproteins underlies the normal resistance of mice to atherosclerosis, an apoB-initiated pathological process

  • We showed that STZ-induced diabetes did not lead to a major change in lipoproteins in chow-fed Human apoB transgenic mice (HuBTg) mice

Read more

Summary

Introduction

The effects of diabetes and lipoprotein lipase (LpL) on plasma lipids were studied in mice expressing human apolipoprotein B (HuBTg). On the WTD, male diabetic HuBTg mice had a Ͼ50% increase in plasma cholesterol and more very low density lipoprotein (VLDL) cholesterol and triglyceride as assessed by FPLC analysis. Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis. A second etiology of diabetic hypertriglyceridemia is a reduction in the activity of lipoprotein lipase (LpL) This results in decreased triglyceride lipolysis in peripheral tissues such as adipose and muscle, and return of more triglyceride to the liver. Human apoB transgenic mice (HuBTg) have increased cholesterol and triglyceride levels and develop atherosclerosis on high fat diets with [10, 11] or without added cholic acid [12]. In a relatively small group of mice, we tested whether the diabetes would lead to a marked increase in atherosclerotic lesions

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.